Bob

[ReNerve Ltd (ASX: RNV) @ReNerveLtd]

We've received marketing approval for our NervAlign® Nerve Cuff in Indonesia. Indonesia joins ReNerve's growing Asia-Pacific footprint alongside the United States, New Zealand, Hong Kong, Thailand and Malaysia.

As the world's fourth most populous nation, with over 280 million people, Indonesia represents one of the largest single-country opportunities in our regional strategy. The approval opens access to Southeast Asia's largest economy and one of the region's most significant addressable markets for nerve repair.

This approval is a significant milestone in our Asia-Pacific expansion strategy, and we look forward to working with our partners to bring the NervAlign® Nerve Cuff to Indonesian clinicians and patients.

Read the full $RNV ASX Announcement here: https://t.co/azQ305piTe

#NerveRepair #PeripheralNerveRepair #Indonesia #MedicalDevices #AsiaPacific #MedTech

[ReNerve Ltd (ASX: RNV) @ReNerveLtd]

We’ve received marketing approval for our NervAlign® Nerve Cuff in the Philippines. This milestone opens access to one of Southeast Asia’s largest and fastest-growing healthcare markets, representing a significant opportunity for nerve repair solutions. With a population of more than 115 million people, the Philippines is the second most populous nation in Southeast Asia and a key market within ReNerve’s regional growth strategy.

The Asia-Pacific nerve repair market is estimated to reach approximately US$100million in 2026, and the Philippines’ growing healthcare needs, including a high burden of trauma and diabetes-related nerve injuries - make it a strategically important market for expanding access to innovative nerve repair technologies.

“Securing approval in the Philippines is a significant milestone in our Asia-Pacific expansion strategy. The Philippines is one of the largest and fastest-growing healthcare markets in the region, and the clinical need for effective peripheral nerve repair, driven by both trauma and diabetes is substantial,” ReNerve CEO Dr Julian Chick said.

“This approval is further validation of the strength of our clinical data and the clear benefit the NervAlign® Nerve Cuff delivers to patients and surgeons. We look forward to working with our partners to bring the product to Filipino clinicians and patients.”

Read the full ASX release here: https://t.co/fIXUUVXcTa

#ReNerve #ASXRNV #MedTech #PeripheralNerveRepair #Biomaterials

[ReNerve Ltd (ASX: RNV) @ReNerveLtd]

ReNerve wins Philippines marketing approval for NervAlign Nerve Cuff | Media via @StockWireX

https://t.co/qZKS74YTiP

[ReNerve Ltd (ASX: RNV) @ReNerveLtd]

ReNerve Secures Philippine Marketing Approval for NervAlign® Nerve Cuff | Media via @sharecafetweets

https://t.co/KYoyEYJtX3

[ReNerve Ltd (ASX: RNV) @ReNerveLtd]

We’ve received marketing registration approval from India’s Central Drugs Standard Control Organisation (CDSCO) for our NervAlign® Nerve Cuff. This marks ReNerve’s first product approval in the significant and rapidly growing Indian market and clears the way for ReNerve and its commercialisation partner, NetCentrix Ventures, to roll out the NervAlign® Nerve Cuff across India.

As the world’s most populous nation, with more than 1.45 billion people, India is a key market in ReNerve’s global commercialisation strategy. The country’s nerve repair and regeneration market is estimated to be worth approximately US$700 million in 2025, supported by strong demand and one of the highest rates of road-trauma injuries globally.

“Securing marketing approval in India is a landmark milestone for ReNerve. India is the world’s most populous country and one of the largest and fastest-growing healthcare markets globally, and the clinical need for effective peripheral nerve repair, driven by significant number of trauma cases, is enormous,” said Dr Julian Chick, CEO of ReNerve.

Read the full ASX release here: https://t.co/AHJJcN28FN

#ReNerve #ASXRNV #MedTech #PeripheralNerveRepair #Biomaterials

[Bob @JimB26403784]

@sophieelsworth Does anyone know if his brother or girlfriend survived?

[Bob @JimB26403784]

@benonwine Absolutely!!

[Bob @JimB26403784]

@UKRRichard One of history's great leaders.

[Bob @JimB26403784]

@Neccccy Legend!

[Bob @JimB26403784]

@ianwrightey Hi Ian, not sure if you will get this 7 years later.....just wondering if you are on Instagram or FB and still posting about your travels?! Thanks!

[Bob @JimB26403784]

@LFC Divok Origi vibes!

[Bob @JimB26403784]

@ESPNUK Gerrard picked Suarez!

[Bob @JimB26403784]

@LFCUNLOCKED I thought it was in Arabic

[Bob @JimB26403784]

@snappedlfc Copy of John Barnes in the Maracana 1984!!?

[Bob @JimB26403784]

@Sarahjanelov @guyalepage Hi Sarah, just wanted to say your video with Modjo is iconic and you represent so many people's teenage years! Thank you and I hope you are happy and well.

[Bob @JimB26403784]

@BehizyTweets He could have put that slightly better....

[Bob @JimB26403784]

@TheAnfieldBuzz @kungfunahi Proper fans.

[Bob @JimB26403784]

@AnfieldRd96 Bradley 100%

[Bob @JimB26403784]

@MartinHN @SkySportsNews Peter Crouch would be jealous of their goal celebrations.

[Bob @JimB26403784]

@Badruskyy @AnfieldWatch Isak plus cash for Nunez of course 😂